Phibro(PAHC)

Search documents
Phibro(PAHC) - 2022 Q1 - Earnings Call Transcript
2021-11-06 03:51
Phibro Animal Health Corporation (NASDAQ:PAHC) Q3 2022 Earnings Conference Call November 3, 2021 9:00 AM ET Company Participants Damian Finio - CFO Jack Bendheim - Chairman, President and CEO Daniel Bendheim - Director and EVP, Corporate Strategy Conference Call Participants Erin Wright - Morgan Stanley Michael Ryskin - Bank of America David Westenberg - Guggenheim Securities Operator Good morning. My name is Shantel, and I will be your conference operator today. At this time, I would like to welcome everyo ...
Phibro(PAHC) - 2022 Q1 - Quarterly Report
2021-11-02 20:31
Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2021 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 001-36410 Phibro Animal Health Corporation (Exact name of registrant as specified in its charter) Delaware 13 ...
Phibro(PAHC) - 2021 Q4 - Earnings Call Transcript
2021-08-26 15:52
Phibro Animal Health Corporation (NASDAQ:PAHC) Q4 2021 Earnings Conference Call August 26, 2021 9:00 AM ET Company Participants Damian Finio - CFO Jack Bendheim - Chairman, President and CEO Donny Bendheim - Director and EVP, Corporate Strategy Conference Call Participants Katie Tryhane - Credit Suisse Michael Ryskin - Bank of America Operator Thank you for standing by and welcome to the Phibro Animal Health Corporation Q4 2020 (sic) [2021] Conference Call. At this time, all participants are in a listen-onl ...
Phibro(PAHC) - 2021 Q4 - Annual Report
2021-08-25 20:32
Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K (Mark One) ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended June 30, 2021 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 001-36410 | Class A Common Stock, $0.0001 | | | | --- | --- | --- | | Title of each class par value per share | Trading Sy ...
Phibro(PAHC) - 2021 Q3 - Earnings Call Transcript
2021-05-09 19:31
Phibro Animal Health Corporation (NASDAQ:PAHC) Q3 2021 Earnings Conference Call May 7, 2021 9:00 AM ET Company Participants Damian Finio - Chief Financial Officer Jack Bendheim - Chairman, President & Chief Executive Officer Donny Bendheim - Director & Executive Vice President of Corporate Strategy Conference Call Participants David Westenberg - Guggenheim Securities Erin Wright - Credit Suisse Michael Ryskin - Bank of America Kevin Kedra - G. Research Operator Good day and thank you for standing by. Welco ...
Phibro(PAHC) - 2021 Q3 - Earnings Call Presentation
2021-05-07 20:02
Phibro Animal Health Corporation Financial Results Third Quarter - ended March 31, 2021 Fiscal Year 2021 Webcast and Conference Call May 7, 2021 U.S. toll-free +1-833-968-1955 International toll +1-647-689-6656 Conference ID: 2181337 Important Information Cautionary Statement Regarding Forward-Looking Statements This communication contains forward-looking statements that are subject to risks and uncertainties, including with respect to future debt and leverage levels. All statements other than statements of ...
Phibro(PAHC) - 2021 Q3 - Quarterly Report
2021-05-06 20:34
Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2021 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from ________to______ Commission File Number: 001-36410 Phibro Animal Health Corporation incorporation or organization) Identification No.) Glenp ...
Phibro(PAHC) - 2021 Q2 - Earnings Call Transcript
2021-02-05 20:53
Phibro Animal Health Corp (NASDAQ:PAHC) Q2 2021 Results Conference Call February 4, 2021 9:00 AM ET Company Participants Damian Finio - CFO Jack Bendheim - CEO Conference Call Participants David Westenberg - Guggenheim Securities Balaji Prasad - Barclays Haley Christofides - Credit Suisse Michael Ryskin - BofA Securities Kevin Kedra - G. Research Melina Santoro - Morgan Stanley Operator Ladies and gentlemen, thank you for standing by, and welcome to the Phibro Animal Health Corporation Q2 2021 Conferenc ...
Phibro(PAHC) - 2021 Q2 - Earnings Call Presentation
2021-02-04 18:55
Phibro Animal Health Corporation Financial Results Second Quarter - ended December 31, 2020 Fiscal Year 2021 Webcast and Conference Call February 4, 2021 U.S. toll-free +1-833-968-1955 International toll +1-647-689-6656 Conference ID: 3288725 Important Information Cautionary Statement Regarding Forward-Looking Statements This communication contains forward-looking statements that are subject to risks and uncertainties. All statements other than statements of historical or current fact included in this repor ...
Phibro(PAHC) - 2021 Q2 - Quarterly Report
2021-02-03 21:31
Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended December 31, 2020 Glenpointe Centre East, 3rd Floor 07666-6712 300 Frank W. Burr Boulevard, Suite 21 (Zip Code) Teaneck, New Jersey (Address of Principal Executive Offices) (201) 329-7300 OR (Registrant's telephone number, including area code) ☐ TRANSITION REPORT PURSUANT TO SECT ...